First Time Loading...

Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 54.92 USD -2.23%
Updated: Apr 25, 2024

Intrinsic Value

Enovis Corp is a US-based company operating in Health Care Equipment & Supplies industry. [ Read More ]

The intrinsic value of one ENOV stock under the Base Case scenario is 69.81 USD. Compared to the current market price of 54.92 USD, Enovis Corp is Undervalued by 21%.

Key Points:
ENOV Intrinsic Value
Base Case
69.81 USD
Undervaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Enovis Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ENOV stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Enovis Corp

Provide an overview of the primary business activities
of Enovis Corp.

What unique competitive advantages
does Enovis Corp hold over its rivals?

What risks and challenges
does Enovis Corp face in the near future?

Has there been any significant insider trading activity
in Enovis Corp recently?

Summarize the latest earnings call
of Enovis Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Enovis Corp.

Provide P/S
for Enovis Corp.

Provide P/E
for Enovis Corp.

Provide P/OCF
for Enovis Corp.

Provide P/FCFE
for Enovis Corp.

Provide P/B
for Enovis Corp.

Provide EV/S
for Enovis Corp.

Provide EV/GP
for Enovis Corp.

Provide EV/EBITDA
for Enovis Corp.

Provide EV/EBIT
for Enovis Corp.

Provide EV/OCF
for Enovis Corp.

Provide EV/FCFF
for Enovis Corp.

Provide EV/IC
for Enovis Corp.

Show me price targets
for Enovis Corp made by professional analysts.

What are the Revenue projections
for Enovis Corp?

How accurate were the past Revenue estimates
for Enovis Corp?

What are the Net Income projections
for Enovis Corp?

How accurate were the past Net Income estimates
for Enovis Corp?

What are the EPS projections
for Enovis Corp?

How accurate were the past EPS estimates
for Enovis Corp?

What are the EBIT projections
for Enovis Corp?

How accurate were the past EBIT estimates
for Enovis Corp?

Compare the revenue forecasts
for Enovis Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Enovis Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Enovis Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Enovis Corp compared to its peers.

Compare the P/E ratios
of Enovis Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Enovis Corp with its peers.

Analyze the financial leverage
of Enovis Corp compared to its main competitors.

Show all profitability ratios
for Enovis Corp.

Provide ROE
for Enovis Corp.

Provide ROA
for Enovis Corp.

Provide ROIC
for Enovis Corp.

Provide ROCE
for Enovis Corp.

Provide Gross Margin
for Enovis Corp.

Provide Operating Margin
for Enovis Corp.

Provide Net Margin
for Enovis Corp.

Provide FCF Margin
for Enovis Corp.

Show all solvency ratios
for Enovis Corp.

Provide D/E Ratio
for Enovis Corp.

Provide D/A Ratio
for Enovis Corp.

Provide Interest Coverage Ratio
for Enovis Corp.

Provide Altman Z-Score Ratio
for Enovis Corp.

Provide Quick Ratio
for Enovis Corp.

Provide Current Ratio
for Enovis Corp.

Provide Cash Ratio
for Enovis Corp.

What is the historical Revenue growth
over the last 5 years for Enovis Corp?

What is the historical Net Income growth
over the last 5 years for Enovis Corp?

What is the current Free Cash Flow
of Enovis Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Enovis Corp.

Financials

Balance Sheet Decomposition
Enovis Corp

Current Assets 896.5m
Cash & Short-Term Investments 36.2m
Receivables 291.5m
Other Current Assets 568.8m
Non-Current Assets 3.6B
PP&E 334.3m
Intangibles 3.2B
Other Non-Current Assets 90.3m
Current Liabilities 369.6m
Accounts Payable 132.5m
Accrued Liabilities 219.8m
Other Current Liabilities 17.3m
Non-Current Liabilities 721.3m
Long-Term Debt 466.2m
Other Non-Current Liabilities 255.2m
Efficiency

Earnings Waterfall
Enovis Corp

Revenue
1.7B USD
Cost of Revenue
-713.8m USD
Gross Profit
993.4m USD
Operating Expenses
-973.5m USD
Operating Income
19.9m USD
Other Expenses
-53.1m USD
Net Income
-33.3m USD

Free Cash Flow Analysis
Enovis Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ENOV Profitability Score
Profitability Due Diligence

Enovis Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
Positive Free Cash Flow
46/100
Profitability
Score

Enovis Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

ENOV Solvency Score
Solvency Due Diligence

Enovis Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Average Altman Z-Score
49/100
Solvency
Score

Enovis Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENOV Price Targets Summary
Enovis Corp

Wall Street analysts forecast ENOV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENOV is 76.7 USD with a low forecast of 65.65 USD and a high forecast of 86.1 USD.

Lowest
Price Target
65.65 USD
20% Upside
Average
Price Target
76.7 USD
40% Upside
Highest
Price Target
86.1 USD
57% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ENOV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ENOV Price
Enovis Corp

1M 1M
-9%
6M 6M
+24%
1Y 1Y
-5%
3Y 3Y
-22%
5Y 5Y
-22%
10Y 10Y
-22%
Annual Price Range
54.92
52w Low
43.67
52w High
65.54
Price Metrics
Average Annual Return -22.78%
Standard Deviation of Annual Returns
N/A
Max Drawdown -38%
Shares Statistics
Market Capitalization 3B USD
Shares Outstanding 55 000 000
Percentage of Shares Shorted 9.05%

ENOV Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Enovis Corp Logo
Enovis Corp

Country

United States of America

Industry

Health Care

Market Cap

3B USD

Dividend Yield

0%

Description

Enovis Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. Enovis Corporation, formerly Colfax Corporation, is a medical technology company that provides orthopedic care and fabrication technology products and services under DJO brand. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, and others.

Contact

DELAWARE
Wilmington
2711 Centerville Road, Suite 400
+13022529160.0
https://www.enovis.com/

IPO

2008-05-08

Employees

16 200

Officers

CEO & Chairman
Mr. Matthew L. Trerotola
President, COO & Director
Mr. Brady R. Shirley
Senior VP & Chief Human Resources Officer
Ms. Patricia A. Lang
Executive Vice President of Strategy & Business Development
Mr. Daniel A. Pryor
Senior VP & CFO
Mr. Phillip Benjamin Berry
VP, Controller & Chief Accounting Officer
Mr. John Kleckner
Show More
Vice President of Investor Relations
Derek Leckow
Senior VP & Chief Legal Officer
Mr. Bradley J. Tandy
Vice President of Corporate Communication
Katie Sweet
Group President Prevention & Recovery
Mr. Terry Ross
Show Less

See Also

Discover More
What is the Intrinsic Value of one ENOV stock?

The intrinsic value of one ENOV stock under the Base Case scenario is 69.81 USD.

Is ENOV stock undervalued or overvalued?

Compared to the current market price of 54.92 USD, Enovis Corp is Undervalued by 21%.